3 results about "Nelumbo nucifera" patented technology

This invention relates to a decoction process and equipment for treating non-alcoholic fatty liver disease (NAFLD). The raw materials of the decoction, by weight, are: 15 parts Artemisia capillaris, 10 parts Gardenia jasminoides, 10 parts Crataegus pinnatifida, 10 parts Bupleurum chinense, 15 parts stir-fried Paeonia lactiflora, 10 parts Citrus aurantium, 5 parts Glycyrrhiza uralensis, 10 parts Nelumbo nucifera, 15 parts Cassia tora, 10 parts Gynostemma pentaphyllum, 30 parts Benincasa hispida peel, 15 parts Salvia miltiorrhiza, and 9 parts Atractylodes lancea. The equipment includes a decoction container and a container lid. A connecting column is provided on the lower surface of the container lid. A first medicine-carrying mesh tray is fixed at the bottom of the connecting column. A second medicine-carrying mesh tray is longitudinally hinged to each side of the first medicine-carrying mesh tray. A rotating sleeve is provided on the upper part of the connecting column. The rotating sleeve is connected to the outer side of the second medicine-carrying mesh tray through multiple stainless steel ropes. This invention transforms the traditional wisdom of batch decoction in traditional Chinese medicine into a standard process that can be executed by modern automated equipment, and provides a standardized decoction solution for the treatment of NAFLD with traditional Chinese medicine that is more effective, safer to use, and easier to operate.

This invention provides a fermented traditional Chinese medicine powder for women, which is related to the field of pharmaceutical technology. Based on dry weight, it is composed of the following raw materials: Astragalus membranaceus 15 parts, Citrus aurantium 9 parts, Polygonatum odoratum 9 parts, Angelica dahurica 6 parts, Longan aril 12 parts, Lilium brownii 6 parts, Lycium barbarum 12 parts, Poria cocos 9 parts, Nelumbo nucifera 9 parts, Lophatherum gracile 6 parts, Polygonatum sibiricum 15 parts, Morus alba 15 parts, Pueraria lobata 9 parts, Ziziphus jujuba var. spinosa 6 parts, Angelica sinensis 9 parts, Ganoderma lucidum 15 parts, and Ziziphus jujuba 9 parts. The powder is produced through solid-state fermentation with compound probiotics, low-temperature drying, ultra-fine pulverization, and irradiation sterilization. The fermented Chinese herbal powder for women, which is a formula for replenishing qi and blood, provided by this invention, solves the problems of poor targeting and insufficient precision in conditioning of existing tonifying medicines for women's physiological characteristics. It can effectively improve the sub-health state of women caused by insufficient qi and blood, deficiency of yin fluids, and restlessness, such as insomnia, dreaminess, sallow complexion, dull skin, fatigue, dizziness, and palpitations.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a pharmaceutical composition for treating simple obesity of spleen deficiency and dampness retention type and its application. This pharmaceutical composition is prepared based on seven traditional Chinese medicines listed in the Food and Drug Catalogue: Codonopsis pilosula, Poria cocos, Coix lacryma-jobi, Dioscorea opposita, Nelumbo nucifera, Lilium brownii, and Ziziphus jujuba. The pharmaceutical composition provided by this invention improves the condition of swollen, pale, and white-coated tongue in rats with simple obesity of spleen deficiency and dampness retention type, and improves abnormal lipid metabolism; it can effectively regulate abnormalities in serum BUN, UA, MTL, VIP, and other indicators in rats with simple obesity of spleen deficiency and dampness retention type, improve gastrointestinal emptying, enhance gastrointestinal motility, and increase the calcium content of myocardial cell membranes. 2+ -ATPase, Na + -K + - It increases ATPase activity, improves cellular energy metabolism, and reduces the risk of cardiovascular disease caused by obesity; it inhibits the expression levels of BUN and UA, which can treat obesity-induced hyperuricemia and improve renal metabolism. It also exerts a therapeutic effect on simple obese rats with spleen deficiency and dampness retention.